Literature DB >> 29572486

SETD2 - linking stem cell survival and transformation.

Mrinal M Patnaik1, Omar Abdel-Wahab2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29572486      PMCID： PMC5939039          DOI： 10.1038/s41422-018-0025-7

Source DB:  PubMed          Journal:  Cell Res        ISSN： 1001-0602            Impact factor:   25.617


× No keyword cloud information.
  10 in total

Review 1.  Understanding the language of Lys36 methylation at histone H3.

Authors:  Eric J Wagner; Phillip B Carpenter
Journal:  Nat Rev Mol Cell Biol       Date:  2012-01-23       Impact factor: 94.444

Review 2.  SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.

Authors:  Catherine C Fahey; Ian J Davis
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

3.  Identification of functional cooperative mutations of SETD2 in human acute leukemia.

Authors:  Xiaofan Zhu; Fuhong He; Huimin Zeng; Shaoping Ling; Aili Chen; Yaqin Wang; Xiaomei Yan; Wei Wei; Yakun Pang; Hui Cheng; Chunlan Hua; Yue Zhang; Xuejing Yang; Xin Lu; Lihua Cao; Lingtong Hao; Lili Dong; Wei Zou; Jun Wu; Xia Li; Si Zheng; Jin Yan; Jing Zhou; Lixia Zhang; Shuangli Mi; Xiaojuan Wang; Li Zhang; Yao Zou; Yumei Chen; Zhe Geng; Jianmin Wang; Jianfeng Zhou; Xin Liu; Jianxiang Wang; Weiping Yuan; Gang Huang; Tao Cheng; Qian-Fei Wang
Journal:  Nat Genet       Date:  2014-02-09       Impact factor: 38.330

4.  Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.

Authors:  Yuan-Liang Zhang; Jie-Wen Sun; Yin-Yin Xie; Yan Zhou; Ping Liu; Jia-Chun Song; Chun-Hui Xu; Lan Wang; Dan Liu; Ai-Ning Xu; Zhu Chen; Sai-Juan Chen; Xiao-Jian Sun; Qiu-Hua Huang
Journal:  Cell Res       Date:  2018-03-12       Impact factor: 25.617

5.  Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.

Authors:  Tetsuichi Yoshizato; Bogdan Dumitriu; Kohei Hosokawa; Hideki Makishima; Kenichi Yoshida; Danielle Townsley; Aiko Sato-Otsubo; Yusuke Sato; Delong Liu; Hiromichi Suzuki; Colin O Wu; Yuichi Shiraishi; Michael J Clemente; Keisuke Kataoka; Yusuke Shiozawa; Yusuke Okuno; Kenichi Chiba; Hiroko Tanaka; Yasunobu Nagata; Takamasa Katagiri; Ayana Kon; Masashi Sanada; Phillip Scheinberg; Satoru Miyano; Jaroslaw P Maciejewski; Shinji Nakao; Neal S Young; Seishi Ogawa
Journal:  N Engl J Med       Date:  2015-07-02       Impact factor: 91.245

6.  SETD2 alterations impair DNA damage recognition and lead to resistance to chemotherapy in leukemia.

Authors:  Brenton G Mar; S Haihua Chu; Josephine D Kahn; Andrei V Krivtsov; Richard Koche; Cecilia A Castellano; Jacob L Kotlier; Rebecca L Zon; Marie E McConkey; Jonathan Chabon; Ryan Chappell; Peter V Grauman; James J Hsieh; Scott A Armstrong; Benjamin L Ebert
Journal:  Blood       Date:  2017-10-10       Impact factor: 22.113

7.  Enteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2.

Authors:  Andrea B Moffitt; Sarah L Ondrejka; Matthew McKinney; Rachel E Rempel; John R Goodlad; Chun Huat Teh; Sirpa Leppa; Susanna Mannisto; Panu E Kovanen; Eric Tse; Rex K H Au-Yeung; Yok-Lam Kwong; Gopesh Srivastava; Javeed Iqbal; Jiayu Yu; Kikkeri Naresh; Diego Villa; Randy D Gascoyne; Jonathan Said; Magdalena B Czader; Amy Chadburn; Kristy L Richards; Deepthi Rajagopalan; Nicholas S Davis; Eileen C Smith; Brooke C Palus; Tiffany J Tzeng; Jane A Healy; Patricia L Lugar; Jyotishka Datta; Cassandra Love; Shawn Levy; David B Dunson; Yuan Zhuang; Eric D Hsi; Sandeep S Dave
Journal:  J Exp Med       Date:  2017-04-19       Impact factor: 14.307

8.  Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes.

Authors:  Gillian L Dalgliesh; Kyle Furge; Chris Greenman; Lina Chen; Graham Bignell; Adam Butler; Helen Davies; Sarah Edkins; Claire Hardy; Calli Latimer; Jon Teague; Jenny Andrews; Syd Barthorpe; Dave Beare; Gemma Buck; Peter J Campbell; Simon Forbes; Mingming Jia; David Jones; Henry Knott; Chai Yin Kok; King Wai Lau; Catherine Leroy; Meng-Lay Lin; David J McBride; Mark Maddison; Simon Maguire; Kirsten McLay; Andrew Menzies; Tatiana Mironenko; Lee Mulderrig; Laura Mudie; Sarah O'Meara; Erin Pleasance; Arjunan Rajasingham; Rebecca Shepherd; Raffaella Smith; Lucy Stebbings; Philip Stephens; Gurpreet Tang; Patrick S Tarpey; Kelly Turrell; Karl J Dykema; Sok Kean Khoo; David Petillo; Bill Wondergem; John Anema; Richard J Kahnoski; Bin Tean Teh; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2010-01-06       Impact factor: 49.962

9.  DNMT3A and TET2 compete and cooperate to repress lineage-specific transcription factors in hematopoietic stem cells.

Authors:  Xiaotian Zhang; Jianzhong Su; Mira Jeong; Myunggon Ko; Yun Huang; Hyun Jung Park; Anna Guzman; Yong Lei; Yung-Hsin Huang; Anjana Rao; Wei Li; Margaret A Goodell
Journal:  Nat Genet       Date:  2016-07-18       Impact factor: 38.330

10.  Inhibiting WEE1 Selectively Kills Histone H3K36me3-Deficient Cancers by dNTP Starvation.

Authors:  Sophia X Pfister; Enni Markkanen; Yanyan Jiang; Sovan Sarkar; Mick Woodcock; Giulia Orlando; Ioanna Mavrommati; Chen-Chun Pai; Lykourgos-Panagiotis Zalmas; Neele Drobnitzky; Grigory L Dianov; Clare Verrill; Valentine M Macaulay; Songmin Ying; Nicholas B La Thangue; Vincenzo D'Angiolella; Anderson J Ryan; Timothy C Humphrey
Journal:  Cancer Cell       Date:  2015-11-09       Impact factor: 31.743
  10 in total
  3 in total

1.  Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma.

Authors:  You Zhou; Xiao Zheng; Bin Xu; Haifeng Deng; Lujun Chen; Jingting Jiang
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

2.  Methyltransferase SETD2 inhibits tumor growth and metastasis via STAT1-IL-8 signaling-mediated epithelial-mesenchymal transition in lung adenocarcinoma.

Authors:  Xin Yang; Rui Chen; Yan Chen; You Zhou; Chen Wu; Qing Li; Jun Wu; Wen-Wei Hu; Wei-Qing Zhao; Wei Wei; Jun-Tao Shi; Mei Ji
Journal:  Cancer Sci       Date:  2022-02-22       Impact factor: 6.716

3.  SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.

Authors:  Bing-Yi Chen; Junhong Song; Cheng-Long Hu; Shu-Bei Chen; Qunling Zhang; Chun-Hui Xu; Ji-Chuan Wu; Dan Hou; Ming Sun; Yuan-Liang Zhang; Na Liu; Peng-Cheng Yu; Ping Liu; Li-Juan Zong; Jia-Ying Zhang; Ruo-Fei Dai; Fei Lan; Qiu-Hua Huang; Su-Jiang Zhang; Stephen D Nimer; Zhu Chen; Sai-Juan Chen; Xiao-Jian Sun; Lan Wang
Journal:  Blood       Date:  2020-06-18       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.